INDV.L

Indivior Plc
Indivior PLC - Transaction in Own Shares
7th January 2025, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 2906S
Indivior PLC
07 January 2025
 

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

January 7, 2025

INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 141,363 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from December 30, 2024, up to and including January 3, 2025, in connection with its $100m Share Repurchase Program. Aggregated information on the purchase of these shares can be found in the table below.

Following the purchase and cancellation of the above shares (including those purchased but not yet settled), Indivior has 124,828,603 ordinary shares of $0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (124,828,603) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Indivior under the FCA's Disclosure Guidance and Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is defined in the rules of the London Stock Exchange) and "on market" for the purposes of the Companies Act 2006.

Aggregated information

Trading Date

Trading Venue

Aggregated daily volume (number of shares)

Daily weighted average purchase price of the shares (p)

30/12/2024

LSE

40,945

975.63

30/12/2024

BATE

2,428

969.81

30/12/2024

CHIX

10,282

969.40

30/12/2024

AQUIS

391

967.13

31/12/2024

LSE

6,667

994.13

31/12/2024

BATE

3,059

990.74

31/12/2024

CHIX

2,324

992.82

31/12/2024

AQUIS

263

989.57

02/01/2025

LSE

36,112

1,017.21

02/01/2025

BATE

508

1,021.00

02/01/2025

CHIX

233

1,018.06

03/01/2025

LSE

17,457

994.80

03/01/2025

BATE

5,230

992.37

03/01/2025

CHIX

12,303

993.13

03/01/2025

AQUIS

3,161

984.03

 

 

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation (EU) No 596/2014, as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU) 2016/1052, a full breakdown of the individual purchases of ordinary shares made by Morgan Stanley & Co. International Plc on behalf of Indivior during the above period as part of the Share Repurchase Program can be found at www.indivior.com/en/investors/shareholder-information/share-repurchase-program.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGZGGMKVGGKZM]]>
TwitterFacebookLinkedIn